Germany
Japan
United Kingdom
China
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Research Areas
View as table DownloadUSD 475.00
2 Weeks
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Rabbit Polyclonal PD-L1 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PD-L1 antibody was raised against a 17 amino acid synthetic peptide from near the center of human PD-L1. The immunogen is located within amino acids 60 - 110 of PD-L1. |
USD 399.00
In Stock
HLA Class I ABC mouse monoclonal antibody, clone W6/32, Purified
| Applications | ELISA, FC, IF, IHC, IP |
| Reactivities | Bovine, Feline, Human, Monkey, Primate |
HLA Class I ABC mouse monoclonal antibody, clone W6/32, Low Endotoxin
| Applications | ELISA, FC, FN, IF, IHC, IP |
| Reactivities | Bovine, Chimpanzee, Feline, Human, Macaque, Monkey, Primate, Baboon |
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
Rabbit polyclonal PECAM-1 (Ab-713) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PECAM-1 around the phosphorylation site of tyrosine 713 (T-V-YP-S-E). |
CD34 mouse monoclonal antibody, clone ICO-115, PE
| Applications | FC, IF |
| Reactivities | Human, Rat |
| Conjugation | PE |
Rabbit Polyclonal CD4 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Rabbit |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an C-terminal region of the human CD4 protein (within residues 400-458). [Swiss-Prot P01730] |
Feline Coronavirus mouse monoclonal antibody, clone FIPV3-70, Purified
| Applications | ELISA, FC, IF, IHC, WB |
CD45 (PTPRC) (CD45RC) mouse monoclonal antibody, clone MT2, Aff - Purified
| Applications | FC, IF, IHC |
| Reactivities | Human |
CD283 / TLR3 mouse monoclonal antibody, clone TLR3.7, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Mouse |
PD1 (PDCD1) rabbit polyclonal antibody, Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide corresponding to 16 Amino Acid from near the carboxy terminus of Human PDCD1. |
Frizzled 2 (FZD2) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Peptide with sequence from the internal region of the protein sequence according to NP_001457.1. |
CD68 mouse monoclonal antibody, clone 514H12, Supernatant
| Applications | IF, IHC |
| Reactivities | Human |
DAXX mouse monoclonal antibody, clone DAXX-03, Aff - Purified
| Applications | IF, IP, WB |
| Reactivities | Human |
CD68 mouse monoclonal antibody, clone C68/684, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
Rabbit polyclonal PECAM-1 (Tyr713) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PECAM-1 around the phosphorylation site of tyrosine 713 (T-V-YP-S-E). |
| Modifications | Phospho-specific |
Il6 rat monoclonal antibody, clone MP5-20F3, Purified
| Applications | FC, IF, IHC, IP, NEUT, WB |
| Reactivities | Mouse |
Rabbit Polyclonal antibody to WNT11 (wingless-type MMTV integration site family, member 11)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 310 of WNT11 (Uniprot ID#O96014) |
Rabbit polyclonal IL8 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 72-99 amino acids from the C-terminal region of human IL8. |
Active filters
Applications
- IF
Filter by
Category
Target Symbol
- PDCD1 (60)
- PECAM1 (57)
- CD19 (55)
- ANAPC2 (30)
- ANAPC11 (27)
- PTPRC (25)
- LGALS3 (22)
- MAPK8 (20)
- TYRO3 (16)
- CD5 (15)
- MAPK9 (15)
- CD4 (13)
- CD33 (12)
- CD3E (12)
- FCGR1A (11)
- PTK7 (11)
- CD274 (10)
- IL6 (10)
- TNF (10)
- IL1A (8)
- LEF1 (8)
- CD2 (7)
- CD22 (7)
- CD34 (7)
- IL36G (6)
- FCER2 (5)
- IL2RA (5)
- IL36A (5)
- MME (5)
- IL1B (4)
- IL1RN (4)
- KIT (4)
- NCAM1 (4)
- TLR2 (4)
- TLR3 (4)
- TNFRSF8 (4)
- CD14 (3)
- CD46 (3)
- CD68 (3)
- CD8A (3)
- IL6R (3)
- MAP2K4 (3)
- MS4A1 (3)
- ROCK1 (3)
- ANAPC5 (2)
- APC2 (2)
- CASP1 (2)
- CD74 (2)
- CD79A (2)
- DVL3 (2)
- ESR1 (2)
- FUT4 (2)
- FZD2 (2)
- FZD3 (2)
- FZD4 (2)
- FZD5 (2)
- FZD9 (2)
- IL10 (2)
- IL18 (2)
- IL2 (2)
- IL6ST (2)
- ITGA2B (2)
- POSTN (2)
- ROCK2 (2)
- TCF25 (2)
- TCF7L2 (2)
- TLR4 (2)
- WNT10A (2)
- AGBL5 (1)
- ANAPC10 (1)
- ANAPC13 (1)
- BRAF (1)
- CCP110 (1)
- CD1A (1)
- CD3D (1)
- CD7 (1)
- CD79B (1)
- CEBPD (1)
- CR2 (1)
- CXCL8 (1)
- DVL2 (1)
- ELK3 (1)
- ESR2 (1)
- FZD10 (1)
- FZD6 (1)
- GZMH (1)
- HLA-A (1)
- HLA-B (1)
- HLA-DPB1 (1)
- IK (1)
- IL1R2 (1)
- IL1RL1 (1)
- IL1RL2 (1)
- IL36B (1)
- IL36RN (1)
- IL37 (1)
- IL4 (1)
- ITGAX (1)
- LRP5 (1)
- PD-L1 (1)
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
- Unmodified (32)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- Phospho-specific (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (491)
- Transmembrane (330)
- ES Cell Differentiation/IPS (141)
- Secreted Protein (72)
- Protein Kinase (70)
- Phosphatase (25)
- Adult stem cells (23)
- Transcription Factors (16)
- GPCR (11)
- Induced pluripotent stem cells (9)
- Embryonic stem cells (8)
- Cancer stem cells (5)
- Protease (3)
- Nuclear Hormone Receptor (2)
- Stem cell - Pluripotency (2)
Pathways
- Cell adhesion molecules (CAMs) (177)
- Hematopoietic cell lineage (162)
- T cell receptor signaling pathway (125)
- Progesterone-mediated oocyte maturation (94)
- Primary immunodeficiency (92)
- Pathways in cancer (73)
- Toll-like receptor signaling pathway (64)
- Cell cycle (60)
- Leukocyte transendothelial migration (60)
- Oocyte meiosis (60)
- Ubiquitin mediated proteolysis (60)
- Wnt signaling pathway (59)
- B cell receptor signaling pathway (58)
- Colorectal cancer (56)
- MAPK signaling pathway (55)
- NOD-like receptor signaling pathway (52)
- Fc epsilon RI signaling pathway (43)
- ErbB signaling pathway (40)
- Focal adhesion (40)
- RIG-I-like receptor signaling pathway (39)
- Type II diabetes mellitus (39)
- Adipocytokine signaling pathway (38)
- Fc gamma R-mediated phagocytosis (38)
- Cytokine-cytokine receptor interaction (36)
- Epithelial cell signaling in Helicobacter pylori infection (36)
- GnRH signaling pathway (36)
- Insulin signaling pathway (36)
- Neurotrophin signaling pathway (36)
- Pancreatic cancer (34)
- Graft-versus-host disease (26)
- Basal cell carcinoma (24)
- Melanogenesis (24)
- Prion diseases (21)
- Apoptosis (18)
- Jak-STAT signaling pathway (18)
- Hypertrophic cardiomyopathy (HCM) (16)
- Systemic lupus erythematosus (16)
- Type I diabetes mellitus (16)
- Cytosolic DNA-sensing pathway (14)
- Acute myeloid leukemia (12)
- Endometrial cancer (12)
- Regulation of actin cytoskeleton (12)
- Prostate cancer (10)
- Alzheimer's disease (9)
- Antigen processing and presentation (9)
- Chemokine signaling pathway (9)
- Natural killer cell mediated cytotoxicity (9)
- Adherens junction (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (8)
- TGF-beta signaling pathway (8)
- Thyroid cancer (8)
- Amyotrophic lateral sclerosis (ALS) (6)
- Dilated cardiomyopathy (6)
- Pathogenic Escherichia coli infection (6)
- Allograft rejection (5)
- Asthma (5)
- Endocytosis (5)
- Vascular smooth muscle contraction (5)
- Axon guidance (4)
- Chronic myeloid leukemia (4)
- Glioma (4)
- Complement and coagulation cascades (3)
- Hedgehog signaling pathway (3)
- Non-small cell lung cancer (3)
- Renal cell carcinoma (3)
- Bladder cancer (2)
- Melanoma (2)
- Small cell lung cancer (2)
- Tight junction (2)
- VEGF signaling pathway (2)
- mTOR signaling pathway (2)
- Dorso-ventral axis formation (1)
- Gap junction (1)
- Inositol phosphate metabolism (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Notch signaling pathway (1)
- Phosphatidylinositol signaling system (1)
- Renin-angiotensin system (1)
- Vibrio cholerae infection (1)
- Viral myocarditis (1)